Bleeding Risk under Oral Factor Xa Inhibitors: Meta-analysis of the randomized comparison with Vitamin K Antagonists and Meta-Regression analysis

Journal Title: Journal of Cardiovascular Medicine and Cardiology - Year 2017, Vol 4, Issue 3

Abstract

Background: Randomized trials have shown that oral direct factor Xa inhibitors (ODIXa) offer potential advantages over vitamin K antagonists (VKAs). It is however unclear whether the magnitude of their benefit is similar at the current recommended doses. Objective: We assessed bleeding risks and total mortality associated with ODIXa therapy compared to VKAs among patients with non-valvular atrial fibrillation or acute venous thromboembolic disease.

Authors and Affiliations

Nabila Ferahta, Lukshe Kanagaratnam, Moustapha Dramé, Thomas Vogel, Pierre-Jacques Ambrosi, Pierre-Olivier Lang

Keywords

Related Articles

A Rare Case of Congenital Rubella Syndrome

Introduction : Congenital rubella syndrome (CRS) is a consequence of rubella infection that can occur when the virus is transmitted in utero during maternal primary infection. It still affects 110,000 children around the...

Efficacy and Safety of Different Energy Settings for Atrial Fibrillation Ablation using the Duty-cycled Radiofrequency Ablation Catheter (PVAC)

In recent years, new ablation catheters have been developed to facilitate atrial fibrillation (AF) ablation procedures, including the multi-electrode pulmonary vein ablation catheter (PVAC), capable of using different pr...

Autonomic Innervation from the Aortic Root Ventricular Ganglionated Plexi to the Pulmonary Vein: A Novel Pathway

Background: Autonomic nerve innervation pathway from the ventricular GP to the pulmonary veins (PV) remains unclear. Aim: This study investigates the autonomic innervations from aortic root ventricular GP to the PVs. Ni...

Lactate Dehydrogenase is involved in but not the Target Antigen in Children with Kawasaki Disease

Background: Kawasaki disease (KD) is an acute vasculitis often complicating coronary arterial lesions, and gradually becomes the leading cause of acquired heart disease instead of rheumatism. Previous studies often regar...

Exercise Echocardiography in Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a relatively frequent genetic disease that affects 1/500 human beings. Main problems with this disease are the development of symptoms in 10-20% of affected individuals, and the incre...

Download PDF file
  • EP ID EP232070
  • DOI 10.17352/2455-2976.000048
  • Views 87
  • Downloads 0

How To Cite

Nabila Ferahta, Lukshe Kanagaratnam, Moustapha Dramé, Thomas Vogel, Pierre-Jacques Ambrosi, Pierre-Olivier Lang (2017). Bleeding Risk under Oral Factor Xa Inhibitors: Meta-analysis of the randomized comparison with Vitamin K Antagonists and Meta-Regression analysis. Journal of Cardiovascular Medicine and Cardiology, 4(3), 38-48. https://europub.co.uk/articles/-A-232070